Progress with blood cancer treatments announced on King’s Tour

01 - 6 - 2018

Progress with blood cancer treatments announced on King’s Tour

LIBRA welcomed more than thirty supporters to King’s on 30th May, providing an opportunity to meet with Professors who work tirelessly to tackle blood cancers and blood disorders. Chairman Andrew Lodge presented on the history of the charity over the last 40 years and King's experts provided progress reports on the development of new treatments for patients.

Andrew outlined some of the recent work LIBRA has supported including the new Ambulatory Transplant Unit on the hospitals Davison Ward. He was also delighted to introduce two new LIBRA trustees, Rob Pullinger and Jackie Robinson.

Farzin Farzaneh, Professor of Molecular Medicine, went on to give a very interesting talk on the development of vaccines as a second line treatment for leukaemia when first line treatments such as chemotherapy and radiation are not effective.

LIBRA has supported this work by providing equipment for the manufacture of viral vectors which are used to target the cancer cells in order to introduce the vaccines.

The professor said: “Since the department opened its facility for the manufacture of Investigational Medicinal Products in 2001, it has become the biggest supplier of viral vectors in Europe to support many clinical trials. I would like to thank LIBRA for its great support over many years.”

Dr Shreyans Gandhi, Consultant Haematologist, followed with a fact-filled presentation on novel approaches to the treatment of Myelodysplastic syndrome which is a pre-cursor to Acute Myeloid Leukaemia. This work focuses on individualised treatments tailored to the patient's profile and the mutations that drive the development of the cancer.

He said: “Hundreds of agents are developed in the early stages to target the identified mutations, with about 10% of potential agents reaching phase I clinical trials, where evidence of the efficacy of the treatments is showing promising results.”

During the visit, a donation of £3,000 was presented to LIBRA in memory of Kiran Rahi, who sadly passed away in 2011 after fighting two bouts of Non-Hodgkin's disease over 10 years. His family gave the funds to LIBRA and were pleased to hear how they will be put to good use.

Lion Ranjit Deogun then presented more that £300 on behalf of Bostall Heath Lodge, who raised over £300 at a Ladies Night and £1,200 was awarded from Farnham Lions Club. Follwing donations, tour groups were able to visit the ELF and LIBRA ward and the Ambulatory Transplant Unit.

Amrit Rahi-Deogu, sister of Kiran Rahi, said: "The new unit is amazing. It’s great that LIBRA is able to support these facilities."

Lion Ranjt added: "The presentations were very interesting. It’s wonderful to hear about the new developments in the treatment of leukaemia and how the work of LIBRA has supported this."

Lion Rob Pullinger, Honorary Treasurer and Trustee concluded: "Thank you to all the Lions from clubs across the south east and those from South Africa who attended the event at King's this evening. As always it was fantastic to share the work that Kings' are doing to research new treatments for Leukaemia and how we care continuing to support this vital work."



Post has no comments.

Leave a comment